les indications “borderline” de la crt · 2019. 9. 24. · scientific validation of crt in nyha...

27
Les Indications “borderline” de la CRT Frédéric Anselme Rouen University Hospital

Upload: others

Post on 20-Jul-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Les Indications “borderline”de la CRT

Frédéric AnselmeRouen University Hospital

Page 2: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

What’s a boderline indication for CRT ?

• Proof of superiority of CRT over an alternative therapy is weak or is lacking

• ~ Questionable CRT indication • ~ Class II indication of institutional guidelines

Page 3: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Prognosis of pts with Class I vs Class II CRT indication

Stabile G et al. HeartRhythm 2018 in press

Page 4: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Scientific validation in NYHA class III/IV

• QRS≥120-130ms• LVEF≤35%

0500

1000150020002500300035004000

1999 2000 2001 2002 2003 2004 2005

Cum

ulat

ednu

mbe

rof

patie

nts

Year of publication

PATH CHF

MUSTIC SR

MUSTIC AFMIRACLE

CONTAK CD

MIRACLE ICD

PATH CHF II

COMPANION

MIRACLE ICD II

CARE HF

Page 5: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

What have we learned from studies on CRT in NYHA class III/IV patients ?

• Improvement in symptoms (NYHA) and exercise capacity (6 min walking test, VO2)

• QoL improvement

• LV reverse remodeling (LV volumes, LVEF, MR)

• Reduction in morbidity (hospitalization for HF)• Reduction in mortality (CARE HF)

Page 6: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Scientific validation of CRT in NYHA class II

• 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating CRT-D in NYHA II

Few patients in NYHA I : 18% in REVERSE, 15% in MADIT-CRT and none in RAFTFew patients with CRT-P: 17% in REVERSE and none in MADIT-CRT and RAFT

• Results similar to those of studies evaluating patients in NYHA III/ambulatory IV

Improvement in LV reverse remodeling and HF clinical criteria (REVERSE)Decrease in morbidity (MADIT-CRT) and mortality (RAFT)

Page 7: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Impact of QRS width on CRT clinical benefit

Bryant AR, J Electrocardiol 2013

Page 8: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Impact of QRS Morphology: LBBB

LBBB

Sipahi I, Am Heart J 2012

Strauss DG, Am J Cardiol 2011

Page 9: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Impact of QRS Morphology: no LBBB

Sipahi I, Am Heart J 2012

NoLBBB

Page 10: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Benefit of CRT according to QRS widthand morphology : Registries

• Results similar to that of randomized studies• Wide LBBB QRS provides best response

Peterson PN, JAMA 2013

Page 11: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

2016 CRT Guidelines

LVEF≤35%NYHA II,III, ambulatory IV

LBBB No-LBBB

QRS ≥150msQRS 130-149ms

I-B I-AQRS 130-149ms

IIb-BQRS ≥ 150ms

IIa-B

Sinus Rhythm

Unquestionable 

questionable  IntraV mechanical dysynchrony ?LV electrical delay ?

Page 12: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

2016 CRT Guidelines

HF with reduced LVEFSR/AF

Whatever NYHA class

I-A

Need for Ventricular Pacing

questionable 

His bundle Pacing if narrow native QRS ?

Page 13: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

JACC EP, 2015

Page 14: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

His Bundle Pacing & AVN Ablation for HF patients in uncontrolled AF

Page 15: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

2016 CRT Guidelines

LVEF≤35%NYHA III, ambulatory IV

QRS ≥130ms

IIa-B

Atrial Fibrillation

Provided strategy to ensure biV capture : AV node ablation

questionable - AF ablation ? (PABA CHF; CASTLE-AF)- His bundle Pacing and AV node ablation

If no LBBB /QRS < 149 ms ?

Page 16: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

AF Ablation in CHF patients

Khan M, et al. NEJM 2008;359/1778Marrouche N, et al. NEJM 2018;378:417

CASTLE AFPABA CHF

Page 17: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

2017

BNPBaseline 1 year p

HFpEF 298 ± 212 308 ± 254 0,831

HFref 726± 730 148 ± 232 < 0,001

NYHA

Baseline 1 year p

HFpEF 2,7 ± 0,6 1,4 ± 0,5 < 0,001

HFref 2,9 ± 0,6 1,4 ± 0,4 < 0,001

Page 18: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

2016 CRT Guidelines

Worsening of HF with reduced LVEFSR/AF

High proportion of RV pacing

IIb-B

PM or ICD upgrading

questionable 

Page 19: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Circ Arrhythm Electrophysiol. 2017

Propensity-matchedPatients

AllPatients

Page 20: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Heart Fail Rev Oct. 2017

Page 21: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Conclusion• After 2 decades of CRT experience, it is recognized that patients with borderline indication don’t get as much benefit from CRT as class I indication patients

• We need to question ourselves about alternative therapy or better selection for those patients not fulfilling class I criteria for CRT

• In patients without LBBB, especially if intermediate QRS duration ( need for additional criteria such as LV electrical / mechanical / imaging data)

• In PM / ICD patients candidate for upgrading to BiV pacing (too late ?)• In patients requiring ventricular pacing (His bundle pacing ?)• In patients with AF, catheter ablation should be discussed • In case of borderline indication for CRT, a tailored approach is required

Page 22: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating
Page 23: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating
Page 24: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating
Page 25: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating
Page 26: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Troubles de la conduction et insuffisance cardiaque

• Allongement PR, BBG, BBD, anomalies indéterminées• 30-50% dans l’IC sévère• S’aggravent avec le temps• Facteurs indépendants de mortalité• Induisent un asynchronisme mécanique

Page 27: Les Indications “borderline” de la CRT · 2019. 9. 24. · Scientific validation of CRT in NYHA class II • 3 randomized studies: REVERSE, MADIT-CRT and RAFT, mainly evaluating

Activation électrique dans l’IC avec BBG

• La conduction électrique vers l’endocarde du VG se fait après l’activation du VD, le plus souvent à travers le septum apical

• Activation en « U » du VG avec des lignes fonctionnelles de bloc de conduction

QRS >150ms: région antérieureQRS <150ms: plus latérale

Auricchio A, Circulation 2004